Press Releases August 3, 2026 05:59 PM

NusaTrip Incorporated Notified of Anticipated Delisting from The Nasdaq Stock Market

Nasdaq Announces Anticipated Delisting of NusaTrip Following SEC Trading Suspension

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
NUTR

Nasdaq has notified NusaTrip Incorporated that its securities will be delisted from the exchange on August 12, 2026, unless an appeal is filed. The company's shares have been halted and unavailable for trading since October 23, 2025, following a trading suspension imposed by the SEC. Post-delisting, NusaTrip's shares may trade over-the-counter.

NusaTrip Incorporated Notified of Anticipated Delisting from The Nasdaq Stock Market
NUTR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq to delist NusaTrip securities due to ongoing issues following SEC suspension.
  • NusaTrip's stock trading halted since October 2025, reflecting serious regulatory concerns.
  • Potential trading to continue on over-the-counter markets if delisting proceeds.

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified NusaTrip Incorporated (Nasdaq: NUTR) that its securities will be delisted from the Nasdaq Stock Market LLC on August 12, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market. 

Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104167.pdf) Nasdaq halted trading in the Company’s ordinary shares on October 23, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.

For news and additional information about the company, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.  


Risks

  • Regulatory scrutiny and SEC trading suspension present ongoing compliance risks impacting investor confidence.
  • Delisting may reduce liquidity and visibility for NusaTrip, potentially impacting shareholder value.
  • Appeal outcome is uncertain, creating uncertainty around the company’s market status and future trading.

More from Press Releases

BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients Sep 14, 2026 Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company Sep 14, 2026 NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer Sep 14, 2026 STMicroelectronics introduces automotive image sensor to help scale affordable in-cabin sensing Sep 14, 2026 Baker Hughes and Venture Global Advance Next Phase of U.S. Gas Infrastructure Growth Sep 13, 2026